Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 680 SEK -0.07% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Camurus AB?
Write Note

Camurus AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Camurus AB
Revenue Peer Comparison

Comparables:
CALTX
ORX
S
SECARE
IRLAB A
I
FLERIE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Camurus AB
STO:CAMX
Revenue
kr1.6B
CAGR 3-Years
50%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Revenue
kr1.3B
CAGR 3-Years
1 385%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Orexo AB
STO:ORX
Revenue
kr615.4m
CAGR 3-Years
2%
CAGR 5-Years
-6%
CAGR 10-Years
3%
S
Swedencare AB (publ)
STO:SECARE
Revenue
kr2.5B
CAGR 3-Years
75%
CAGR 5-Years
85%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Revenue
kr5.7m
CAGR 3-Years
N/A
CAGR 5-Years
216%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Revenue
kr100k
CAGR 3-Years
123%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is Camurus AB's Revenue?
Revenue
1.6B SEK

Based on the financial report for Jun 30, 2024, Camurus AB's Revenue amounts to 1.6B SEK.

What is Camurus AB's Revenue growth rate?
Revenue CAGR 5Y
94%

Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Camurus AB have been 50% over the past three years , 94% over the past five years .

Back to Top